TORONTO, April 8, 2013 – Regulators often approve drugs without any hard evidence, relying on the belief that surrogate markers are accurate predictors of the health benefits of the drug being tested. However, researchers including York University Professor Joel Lexchin, say the contrary can be the case. “Sometimes faith is misplaced and these drugs […]